Kaposi sarcoma is a reactive hyperplasia of blood and lymphatic vessels caused by human herpesvirus 8. It has several subtypes including classic, endemic, AIDS-related, and iatrogenic forms. The AIDS-related subtype is the most aggressive and fatal, typically involving the skin, mucosa, lymph nodes, lungs, and GI tract. Prognosis depends on the ACTG staging system, with stage T1S1 having the best 3-year survival rate. Diagnosis is made through biopsy and histopathological examination showing vascular spaces lined by hyperchromatic endothelial cells. Treatment involves surgery, radiation, chemotherapy or antiretroviral therapy depending on the extent of disease.
Kaposi sarcoma is a reactive hyperplasia of blood and lymphatic vessels caused by human herpesvirus 8. It has several subtypes including classic, endemic, AIDS-related, and iatrogenic forms. The AIDS-related subtype is the most aggressive and fatal, typically involving the skin, mucosa, lymph nodes, lungs, and GI tract. Prognosis depends on the ACTG staging system, with stage T1S1 having the best 3-year survival rate. Diagnosis is made through biopsy and histopathological examination showing vascular spaces lined by hyperchromatic endothelial cells. Treatment involves surgery, radiation, chemotherapy or antiretroviral therapy depending on the extent of disease.
Kaposi sarcoma is a reactive hyperplasia of blood and lymphatic vessels caused by human herpesvirus 8. It has several subtypes including classic, endemic, AIDS-related, and iatrogenic forms. The AIDS-related subtype is the most aggressive and fatal, typically involving the skin, mucosa, lymph nodes, lungs, and GI tract. Prognosis depends on the ACTG staging system, with stage T1S1 having the best 3-year survival rate. Diagnosis is made through biopsy and histopathological examination showing vascular spaces lined by hyperchromatic endothelial cells. Treatment involves surgery, radiation, chemotherapy or antiretroviral therapy depending on the extent of disease.